Biotechnology Fund Class Fund Technical Analysis

RYCFX Fund  USD 41.45  -0.28  -0.67%   
Market data as of the 25th of March shows BIOTECHNOLOGY FUND priced at 41.45 per share. Measured indicators report Standard Deviation of 1.22, risk adjusted performance of -0.02, and Mean Deviation of 0.9467. The model examines historical data series to identify measurable trend characteristics. Technical levels are measured against peer distributions.

BIOTECHNOLOGY FUND Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BIOTECHNOLOGY, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BIOTECHNOLOGY
  
BIOTECHNOLOGY FUND's Momentum analyses are specifically helpful, as they help identify potential trend changes using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
BIOTECHNOLOGY FUND intrinsic value attempts to capture underlying worth, separate from current trading levels. For BIOTECHNOLOGY FUND, key inputs include a P/E ratio of 21.12, and a P/B ratio of 3.27.

What if' Analysis

What-if analysis for Biotechnology Fund Class is essentially a historical sensitivity test that shows how changes in the investment horizon could have altered realized return, drawdown, and timing outcomes. The real value is perspective: it shows whether the thesis would have remained investable across different historical windows or depended too heavily on one favorable stretch.
0.00
12/25/2025
 
No Change 0.00  0.0 
In 2 months and 31 days
 
03/25/2026
0.00
An initial  0.00  allocation to BIOTECHNOLOGY FUND on December 25, 2025 held through today would generate 0.00 in net gains. The change equals a 0.0% return on investment in BIOTECHNOLOGY FUND in aggregate over a 90 day window. All data reflects available market observations. The competitive set for BIOTECHNOLOGY FUND includes EValuator Conservative, NATIONWIDE INVESTOR, Prudential Core, BlackRock Conservative, VICTORY DIVERSIFIED, SMI CONSERVATIVE, and Franklin Fund. Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology C... More

Momentum Range Indicators for BIOTECHNOLOGY FUND Dashboard

BIOTECHNOLOGY FUND upside and downside signals reflect how the fund price has behaved relative to recent trading ranges. The information reflects structured market data collected across trading periods.

BIOTECHNOLOGY FUND Volatility and Risk Indicators Dashboard

The risk context for BIOTECHNOLOGY FUND is expressed through volatility and drawdown-related metrics. Each indicator reflects observed variability across the available data window.
Mean reversion is the tendency of BIOTECHNOLOGY FUND's price to return to its historical average after periods of extreme deviation. Some analysts monitor this tendency by comparing BIOTECHNOLOGY FUND's price extremes to fundamental value.
Hype
Prediction
LowEstimatedHigh
40.2541.4542.65
Details
Intrinsic
Valuation
LowRealHigh
40.7241.9243.12
Details
Naive
Forecast
LowNextHigh
39.6340.8442.04
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
41.1543.5445.92
Details
Competitive analysis for BIOTECHNOLOGY FUND compares its financial performance and valuation against sector peers. This relative perspective often changes investment conclusions drawn from standalone analysis.

Technical Indicators

Biotechnology Fund Class Backtested Returns

BIOTECHNOLOGY FUND currently shows a very low volatility profile across the evaluation window. It exhibits a Sharpe Ratio (Efficiency) of -0.0722, indicating negative risk-adjusted returns over the last 3 months. Technical screening detected twenty-one indicators influencing risk dynamics. Please assess metrics such as standard deviation of 1.22, risk-adjusted performance of -0.02, and mean deviation of 0.9467 to validate implied volatility levels. The fund owns a Beta (Market Risk) of 0.76, which means generally lower market sensitivity than the broad market. Returns on BIOTECHNOLOGY FUND tend to trail the broader market in strong rallies but hold up better when sentiment turns negative.
Auto-correlation
    
  -0.31  

Poor reverse predictability

Biotechnology Fund Class shows poor reverse predictability when comparing price series from 25th of December 2025 to 8th of February 2026 against from 8th of February 2026 to 25th of March 2026. A strong serial relationship would imply that BIOTECHNOLOGY FUND's recent trajectory contains information about its near-term direction. With a serial correlation of -0.31, nearly 31.0% of BIOTECHNOLOGY FUND's price variation is attributable to patterns in preceding intervals. Given that Biotechnology Fund Class has negative autocorrelation for the selected time horizon, market participants may evaluate potential contrarian price behavior over comparable future intervals.
Correlation Coefficient-0.31
Spearman Rank Test-0.59
Residual Average0.0
Price Variance1.11
This technical view for BIOTECHNOLOGY FUND centers on price movement and volume signals. All values are presented as reference data.
Price trends for BIOTECHNOLOGY FUND are examined within a technical context. This view summarizes available data without implying outcomes. More Info...

Technical Analysis

Indicator
Time Period
Execute Indicator
This analysis covers thirty-seven data points across the selected time horizon. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biotechnology Fund Class volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Technical Analysis Methodology & Indicators

Technical analysis of BIOTECHNOLOGY FUND focuses on NAV trend behavior and volatility patterns where pricing frequency permits. Support and resistance levels frame risk boundaries for observed price regimes.

For Biotechnology Fund Class, this section uses fund disclosures and market reference feeds and standardizes the results for cross-period comparison. Intraday timing differences may exist.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board
Last reviewed on March 22nd, 2026

BIOTECHNOLOGY FUND Technical Indicators

A technical review of Biotechnology Fund Class can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. This is most useful when investors want to compare trend quality, momentum, and mean-reversion risk before acting.

March 25, 2026 Daily Trend Indicators

A technical review of Biotechnology Fund Class can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. This is most useful when investors want to compare trend quality, momentum, and mean-reversion risk before acting.